These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 8548780)
1. Eradication of interleukin 5-transfected J558L plasmacytomas in mice by hydrogen peroxide-generating Stealth liposomes. Samoszuk MK; Wimley WC; Nguyen V Cancer Res; 1996 Jan; 56(1):87-90. PubMed ID: 8548780 [TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo interactions of D-penicillamine with tumors. Samoszuk M; Nguyen V Anticancer Res; 1996; 16(3A):1219-23. PubMed ID: 8702240 [TBL] [Abstract][Full Text] [Related]
3. Effects of sonicated eosinophils on the in vitro sensitivity of human lymphoma cells to glucose oxidase. Samoszuk MK; Nguyen V; Thomas CT; Jacobson DM Cancer Res; 1994 May; 54(10):2650-3. PubMed ID: 8168093 [TBL] [Abstract][Full Text] [Related]
4. Eosinophils infiltrating interleukin-5 gene-transfected tumors do not suppress tumor growth. Krüger-Krasagakes S; Li W; Richter G; Diamantstein T; Blankenstein T Eur J Immunol; 1993 Apr; 23(4):992-5. PubMed ID: 8458388 [TBL] [Abstract][Full Text] [Related]
5. Targeted liposomal c-myc antisense oligodeoxynucleotides induce apoptosis and inhibit tumor growth and metastases in human melanoma models. Pastorino F; Brignole C; Marimpietri D; Pagnan G; Morando A; Ribatti D; Semple SC; Gambini C; Allen TM; Ponzoni M Clin Cancer Res; 2003 Oct; 9(12):4595-605. PubMed ID: 14555535 [TBL] [Abstract][Full Text] [Related]
6. Vaccination with tumor cells engineered to secrete interleukin 2-immunoglobulin G fusion protein induces tumor rejection. Bulfone-Paus S; von Bernuth H; Rückert R; Wachtlin J; Ungureanu D; Notter M; Krause H; Pohl T; Paus R; Kunzendorf U Cancer Res; 1998 Jul; 58(13):2707-10. PubMed ID: 9661877 [TBL] [Abstract][Full Text] [Related]
7. Immunotoxins containing glucose oxidase and lactoperoxidase with tumoricidal properties: in vitro killing effectiveness in a mouse plasmacytoma cell model. Stanislawski M; Rousseau V; Goavec M; Ito H Cancer Res; 1989 Oct; 49(20):5497-504. PubMed ID: 2790777 [TBL] [Abstract][Full Text] [Related]
8. Efficacy of liposomes and hyperthermia in a human tumor xenograft model: importance of triggered drug release. Kong G; Anyarambhatla G; Petros WP; Braun RD; Colvin OM; Needham D; Dewhirst MW Cancer Res; 2000 Dec; 60(24):6950-7. PubMed ID: 11156395 [TBL] [Abstract][Full Text] [Related]
9. Imaging adenoviral-mediated herpes virus thymidine kinase gene transfer and expression in vivo. Tjuvajev JG; Chen SH; Joshi A; Joshi R; Guo ZS; Balatoni J; Ballon D; Koutcher J; Finn R; Woo SL; Blasberg RG Cancer Res; 1999 Oct; 59(20):5186-93. PubMed ID: 10537296 [TBL] [Abstract][Full Text] [Related]
10. Systemic therapy of experimental breast cancer metastases by mutant vesicular stomatitis virus in immune-competent mice. Ebert O; Harbaran S; Shinozaki K; Woo SL Cancer Gene Ther; 2005 Apr; 12(4):350-8. PubMed ID: 15565179 [TBL] [Abstract][Full Text] [Related]
11. Peritoneal plasmacytomagenesis in mice: comparison of different pristane dose regimens. Potter M; Wax JS J Natl Cancer Inst; 1983 Aug; 71(2):391-5. PubMed ID: 6576197 [TBL] [Abstract][Full Text] [Related]
12. Transformation of epithelial cells stably transfected with H2O2-generating peroxisomal urate oxidase. Chu R; Lin Y; Reddy KC; Pan J; Rao MS; Reddy JK; Yeldandi AV Cancer Res; 1996 Nov; 56(21):4846-52. PubMed ID: 8895731 [TBL] [Abstract][Full Text] [Related]
13. Iron homeostasis in plasmacytoma-bearing mice. Schade SG Cancer Res; 1976 Feb; 36(2 Pt 1):375-8. PubMed ID: 1260742 [TBL] [Abstract][Full Text] [Related]
14. BCL2 accelerates inflammation-induced BALB/c plasmacytomas and promotes novel tumors with coexisting T(12;15) and T(6;15) translocations. Silva S; Kovalchuk AL; Kim JS; Klein G; Janz S Cancer Res; 2003 Dec; 63(24):8656-63. PubMed ID: 14695177 [TBL] [Abstract][Full Text] [Related]
15. A new model of active specific immunotherapy using interleukin-1 and sonicated tumor supernatant in murine tumor system. Moriguchi Y; Kan N; Okino T; Harada T; Yamasaki S; Ichinose Y; Li L; Sugie T; Imamura M J Surg Oncol; 1996 Jun; 62(2):78-85. PubMed ID: 8649045 [TBL] [Abstract][Full Text] [Related]
16. Combinational immunotherapy for established tumors with engineered tumor vaccines and adenovirus-mediated gene transfer. Xiang J; Chen Y; Moyana T Cancer Gene Ther; 2000 Jul; 7(7):1023-33. PubMed ID: 10917205 [TBL] [Abstract][Full Text] [Related]
17. Anaplastic, plasmablastic, and plasmacytic plasmacytomas of mice: relationships to human plasma cell neoplasms and late-stage differentiation of normal B cells. Qi CF; Zhou JX; Lee CH; Naghashfar Z; Xiang S; Kovalchuk AL; Fredrickson TN; Hartley JW; Roopenian DC; Davidson WF; Janz S; Morse HC Cancer Res; 2007 Mar; 67(6):2439-47. PubMed ID: 17363561 [TBL] [Abstract][Full Text] [Related]
18. Interleukin-10 prevents dendritic cell accumulation and vaccination with granulocyte-macrophage colony-stimulating factor gene-modified tumor cells. Qin Z; Noffz G; Mohaupt M; Blankenstein T J Immunol; 1997 Jul; 159(2):770-6. PubMed ID: 9218594 [TBL] [Abstract][Full Text] [Related]
19. Suicide gene therapy using E. coli beta-galactosidase. Farquhar D; Pan BF; Sakurai M; Ghosh A; Mullen CA; Nelson JA Cancer Chemother Pharmacol; 2002 Jul; 50(1):65-70. PubMed ID: 12111114 [TBL] [Abstract][Full Text] [Related]
20. Targeted delivery of oncogene-selective antisense oligonucleotides in neuroectodermal tumors: therapeutic implications. Pastorino F; Brignole C; Marimpietri D; Di Paolo D; Zancolli M; Pagnan G; Ponzoni M Ann N Y Acad Sci; 2004 Dec; 1028():90-103. PubMed ID: 15650235 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]